相关实验视频
Updated: Sep 14, 2025

08:49
Models of Bone Metastasis
Published on: September 4, 2012
42.3K
2009年至2018年期间法国骨转移的流行病学
Clarisse Marchal1, Manon Belhassen1, Gaëlle Désaméricq2
1Pharmaco-Epidémiologie Lyon (PELyon), Lyon F-69007, France.
JBMR plus
|July 22, 2025
概括
骨转移 (BM) 的发病率在法国正在上升,乳腺癌,前列腺癌和肺癌是最常见的原发病地. 与骨相关的事件 (SREs) 是频繁的,需要紧急的管理策略.
科学领域:
- 在瘤学瘤学.
- 流行病学 流行病学
- 公共卫生 公共卫生
背景情况:
- 骨转移 (BM) 是癌症的常见并发症,导致显著的骨相关事件 (SREs).
- 最近的流行病学数据缺乏法国发生的BM患者.
- 了解BM流行病学对于开发有效的患者护理策略至关重要.
研究的目的:
- 描述2009年至2018年期间在法国发生的骨转移 (BM) 的流行病学.
- 分析BM发病率的趋势,并确定原发性癌症类型.
- 评估与骨相关事件 (SREs) 的发生及其管理.
主要方法:
- 使用了法国医疗保险退款数据库 (受益人的总样本).
- 使用住院代码或SRE代码 (病理性骨折,脊柱压缩,高热血症,严重骨疼痛) 识别新的成人BM患者.
- 排除了在纳入前3年内患有原发性肉瘤或流行性骨髓瘤的患者.
主要成果:
- 在10年内确定了6,663名新的BM患者,代表了法国的775,973人.
- 观察到BM的原始发病率显著增加,从2009年至2018年平均年增长8.6%.
- 乳腺癌 (15.8%),前列腺癌 (13.4%) 和肺癌 (12.6%) 是最常见的原发性癌症. 4,737名患者经历了SRE,其中66.4%接受了阿片类药物和39.6%接受了NSAID.
结论:
- 骨转移代表了法国日益严重的公共卫生问题,发病率显著上升.
- 与骨相关事件的高负担强调了需要改进管理和有针对性的干预措施.
- 需要紧急制定具体策略,以应对骨转移和SRE对患者护理的重大影响.
相关概念视频
Bone Disorders
4.0K
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
4.0K
Metastasis
5.7K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.7K
Tumor Progression
6.5K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.5K

